# Flow Cytometry Core

> **NIH NIH P30** · JOSLIN DIABETES CENTER · 2021 · $208,108

## Abstract

CORE 4 - FLOW CYTOMETRY CORE – ABSTRACT
The Joslin Flow Cytometry Core's primary objective is to provide state-of-the-art flow cytometers and cell
sorters, as well as expert operation and advice to its users, so that they can isolate, analyze, and study pure
populations of cells from complex tissues, increase our understanding of diabetes and its complications, and
ultimately develop treatments and cures for diabetes. Much of the research at Joslin focuses on gaining an
understanding of type 1 and type 2 diabetes at the cellular level. This includes studies of the cellular
development of pancreatic beta cells, studies of the development and inflammation of metabolically active
muscle and adipose cells, and studies of the mediators and modifiers of autoimmunity toward beta cells. All of
these research areas require analysis and isolation of well-defined, pure, populations of live cells.
Fluorescence activated cell sorting is currently the best method for rapid isolation of very well defined and
highly purified, live cells. The Joslin Flow Cytometry Core meets this need. Cell sorting technology is
continuously evolving and improving, enabling new approaches to questions in diabetes research. Therefore,
a second mission of the Flow Core is to continually update and modernize to offer the most cutting edge cell
sorting technology to its users. In addition, because flow cytometry is traditionally thought of as an
immunological tool, the Joslin Core's mission includes educational activities that enhance the use of flow
cytometry in other research areas, bringing this technology to new users and stimulating new avenues of
diabetes research.
The specific goals of the Core are:
 1. To offer Joslin researchers the use of reliable, well maintained, cutting edge, and cost-efficient cell
sorting and analysis machines.
 2. To provide training opportunities to Joslin researchers so that they can effectively use flow cytometers
and cell sorters, and to continually educate users regarding new applications in flow cytometry that could
benefit their research.
 3. To update instrumentation in response to new and cutting-edge technology developments, including
upgrades to existing instruments, addition of new instrumentation, and establishment of collaborative
arrangements to help develop and evaluate new technology.

## Key facts

- **NIH application ID:** 10160879
- **Project number:** 5P30DK036836-35
- **Recipient organization:** JOSLIN DIABETES CENTER
- **Principal Investigator:** THOMAS F SERWOLD
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $208,108
- **Award type:** 5
- **Project period:** 1997-02-15 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10160879

## Citation

> US National Institutes of Health, RePORTER application 10160879, Flow Cytometry Core (5P30DK036836-35). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10160879. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*